Our health care system needs to do a better job of diagnosing and supporting people with cannabis-related diseases,” a ...

More than 50 biotech leaders and investors are urging the FDA to disregard a methodologically flawed report on mifepristone.

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

Getting Coca-Cola to use cane sugar rather and ice cream manufacturers to stop their use of synthetic dyes are the latest ...

As mothers of children with this disease, we have wept helplessly in recent months as friends — fellow members of a club we ...

The people most at risk from suicide aren’t adolescents in angst or those experiencing a midlife lull, but men age 75 and ...

A 51-year-old man died last month after receiving an experimental treatment from Sarepta, the third death this year tied to ...

Robert F. Kennedy Jr. just named Mark Cruz, a Klamath member, his top tribal health adviser. In a Q&A, Cruz emphasized tribal ...

ICE officials will be given access to 79 million Medicaid recipients' personal data, including home addresses, to track down ...

In a surprise, a FDA advisory panel voted that risks tied to a GSK blood cancer drug called Blenrep outweighed the benefits ...

WASHINGTON — Congressional Republicans early on Friday morning passed legislation to take back money they had already ...

The FDA will request Sarepta Therapeutics stop all shipments of Elevidys, its gene therapy for Duchenne muscular dystrophy, ...